Загрузка...
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
BACKGROUND: The aim of this study was to evaluate the value of CA15-3 for the diagnostic integration of molecular imaging findings performed with hybrid positron emission tomography and computed tomography (PETCT) technology. METHODS: We retrospectively selected 45 patients with a median age of 60 y...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4038066/ https://ncbi.nlm.nih.gov/pubmed/24886519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-356 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|